Our Brands

About Us

Hygienics is the science of preserving and promoting the health of individuals, communities and the planet. In an age where pharmaceuticals and the food supply are contributing factors in destroying our collective health, it is critical that we look to change this. Our objective is to be part of creating a solution and profit by it as a result of doing it well. Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems with the objective in mind of providing the medical and recreational consumers with the best possible product and experience. The company will grow by; generating revenues from the cultivation and sales of premium grade cannabis derived products, developing and licensing valuable intellectual property assets, making strategic acquisitions, and creating trusted global consumer brands.

The cannabis plant has a history of spiritual and medicinal use dating back thousands of years across many cultures and we are excited to be an advocate of it and be involved in the sector. There are many reasons why people smoke or ingest cannabis for recreational purposes and, in most cases, it’s the most positive and rational way to enhance the quality of life and achieve a work-life balance. Among the benefits are increased creativity, improved athletic performance, enhanced spiritual practice etc. As well it may be a safer alternative to alcohol. Cannabis affects people differently; it depends on the strain, the situation or the method of use. Further benefits are seen in immune function, neuroplasticity, emotional and mood regulation, vascular health and digestive function.

Medical marijuana contains antispasmodic qualities which relax muscles and has shown to be an effective treatment for seizures. Marijuana oils that are rich in cannabidol (CBD), are the preferred method for treatment. The active component of the marijuana plant, cannabinoids, have shown to inhibit tumor growth and kill cancer cells in lab testings. Patients who suffer from chronic pain caused by diabetes, cancer, MS, HIV, and other diseases have been turning to medical marijuana as a way to treat their pain without the use of addictive pharmaceutical medications. Research is limited but studies of the endocannabinoid system suggest benefits may include neuroprotection in MS, epilepsy, other movement disorders, and benefit in a number of mood and anxiety disorders. “Wherever the art of Medicine is loved, there is also a love of Humanity.” – Hippocrates.

As Featured on These News Outlets

Cultivating a Premium Quality Product Line

How do we create the solution to the challenge of providing a secure and extremely high quality form of product to the medical industry and to the recreational market on a consistent basis?  By employing scientific methodology. We cultivate by creating a controlled environment and giving the plants exactly what they need. Instead of touching soil, rock wool, peat, clay or other growth media, nutrients and moisture are delivered to an exposed natural root. This is an enhanced hybrid aeroponic method that along with other proprietary techniques produces higher yields and a superior product on a consistent basis.

Building Trusted Brands

The second core driver of the Green Hygienics business model is to develop unique global brands within the industry or sector. We see the market becoming increasingly competitive and establishing distinct brands for each of our products and service entities will be a market differentiator for the company in the immediate future.

Customers need to be comfortable knowing they are getting exactly what they have come to know and expect whenever and wherever they decide to make a decision to buy a product or service. Successful branding represents a positive response to the sum of people’s perception of a company’s customer service, reputation, and products. We hold that in the highest regard. There are no limitations on how we can achieve this, only the next plateau.

 

01.
Strategic Industry Investment

Our investment philosophy is to pursue unique solutions that are poised for scalability. Each quired brand has access to the other portfolio solutions. These solutions are closely related under the GRYN umbrella. This builds customer loyalty and supports growth across the portfolio.

02.
Innovations in Grower Operations

We have developed some of the most compelling innovations in the medical marijuana industry. These groundbreaking solutions create lower costs of production, higher yields with medical grade consistency.

03.
Intellectual Property Assets

Our team has extensive expertise in technology development and bringing those technologies to market.  Outside of our acquisitions of technology, we will continue to develop new product offerings to serve our customers and industry partners.

04.
Diversification

GRYN understands that the market is growing at a radical pace. In order to meet with market demands and to stay ahead of trends, we leverage a diverse portfolio of offerings, brands and technology. This helps to mitigate trend risks and market anomalies.

"The future of the Medical Marijuana industry in the US and Canada is happening right now, and GRYN is poised to disrupt"

Green Hygienics Holdings Inc.

Corporate Information

Green Hygienics Holdings Inc.

CUSIP Number: 393057203
Listed: OTCPINK
Trading Symbol: GRYN
Shares Outstanding: 34,707,835
Transfer Agent: VStock Transfer

Financial Reporting/Disclosure 

Reporting Status: U.S. Fully Reporting SEC Filer
Audited Financials: Latest Report – April 30, 2018
Fiscal Year End: July 31, 2018
Incorporated In: NV, USA

Service Providers 

Accounting/Auditing Firm:

Lonny Wong

Counsel:

James Parsons

Public Relations

Join Our Newsletter

Sign up today for free and be the first to get notified on new updates

1200 buildings

Forward-Looking Statement

Information contained in this presentation is the property of Green Hygienics Holdings Inc. (GRYN. or the “Company”). This presentation does not constitute, or  form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for or purchase any securities in the Company, nor shall it, or the  fact of its communication, form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment  whatsoever with respect to such securities. The communication of this presentation in or to persons in certain jurisdictions may be restricted by law and  persons who may receive communication of this presentation should inform themselves about, and observe, any such restrictions in advance of  communication to them of this presentation. No securities exchange or affiliated service provider has reviewed or accepts responsibility for the adequacy or  accuracy of the content of this presentation.

The material contained in this presentation is provided solely for your general knowledge and is not intended to be a comprehensive review of all matters and  developments concerning GRYN. or its affiliates. The Company has taken all reasonable care in producing the information contained in this presentation.  This information may contain technical or other inaccuracies, omissions, or typographical errors, for which GRYN. assumes no responsibility. GRYN.  makes no representation or warranty regarding, and assumes no responsibility for, the use, validity, accuracy, completeness, reliability or currency of any  claims, statements or information in this presentation.

To the extent permitted by law, GRYN. and its employees, agents, affiliates and consultants exclude all liability for any loss or damage arising from the use  of, or reliance on, any such information, whether or not caused by any negligent act or omission. Statements in this presentation other than purely historical  information, including statements relating to GRYN’s future plans, objectives or expected results, constitute forward-looking statements within the  meaning of the U.S. federal and Canadian securities laws. Forward-looking statements are based on numerous assumptions and are subject to the risks and  uncertainties inherent in GRYN’s business, including risks inherent in early to development stage start-up ventures. These may include the state of the legal  cannabis agri-sector, global market conditions, the ability of the Company to identify and acquire key assets, the nature of potential business acquisitions,  capital expenditures, successful development of technologies, currency fluctuations, government policy and regulation, geopolitical uncertainty and  environmental regulation. As a result, actual results may vary materially from those described in the forward-looking statements. GRYN. disclaims any  obligation to update any forward-looking statements.

This presentation was prepared to assist interested parties in making their own assessment of GRYN. and its business plans and does not purport to  contain all of the information that a prospective investor may desire. In all cases, interested parties should conduct their own investigation and analysis of the  Company, its assets and the information provided in this presentation. Any and all statements, forecasts, projections and estimates contained in this presentation are based on  management’s current knowledge and no representation or warranty is made as to their accuracy and/or reliability.

Connect with Us for Questions

  (855) 802-0299

Our corporate development team is standing by